Financial markets ended the week with a risk-off mood despite Trump's signature of the $2.2 trillion fiscal package to combat the economic impact of covid-19.
Search results
In the first session of the week, investor sentiment found support on signs of decelerating COVID-19 infections and deaths in the major European economies.
Markets ended the week on an upbeat note as investors saw advanced economies being past the peak of new coronavirus deaths and focused on the release of government guidelines for easing lockdown measures.
Investors traded more cautiously in yesterday's session as they weighted mixed news on Covid-19 vaccine developments and regulators ended their short-selling bans in several European economies. In this context, U.S. and European stocks retreated after Monday's rally.
In yesterday's session, volatility rose as data on new COVID-19 cases rose in the U.S. and investors digested the Federal Reserve adverse description of the economic outlook.
Concerns about a second wave of the coronavirus pandemic dominated investor sentiment in the first session of the week.
In yesterday's session, financial markets experienced risk-off flows as investors were concerned about the spread of new covid-19 cases in the US and media reports suggesting that the White House might be willing to impose new tariffs on $3.1 billion of exports from Europe.
Yesterday investors traded on a risk-on mood on the back of an historical agreement in the EU. The €750bn stimulus plan agreed will consist of €390bn in grants and €360bn in loans.
Financial markets started the week with a mixed session. In Europe, investors traded with a risk-off mood while in the US riskier assets benefited from progress in the negotiations for a new fiscal stimulus package and hopes for a COVID-19 vaccine.
Yesterday, investors in the US traded with optimism as the Federal Reserve kept its official interest rates unchanged and reiterated its intention to "act as appropriate to support the economy".
In the last session of the week, investors continued to digest the Federal Reserve's new inflation approach, in which it will be more tolerant to inflation increases.
Economic indicators favored a greater risk appetite in yesterday's session. China's industrial output rose +5.6% yoy in August while retail sales grew +0.5% and surpassed 2019 levels for the first time since the COVID-19 outbreak. Also, German investor sentiment continued to improve in September according to the ZEW index.
Market risk appetite declined in yesterday's session as investors continued to digest the outcome of the Fed meeting. Stock markets declined across advanced and emerging economies while the safe-haven JPY appreciated.
In the last session of the week, investors traded with a downbeat tone and stock indices declined across Europe and, following a tech sell-off, in the US. Asian equities, instead, increased mildly.
In yesterday's session, investors traded with a risk-off mood amid concerns of growing COVID cases around the globe. Powell's speech in Congress in which he stated that the US economy is improving failed to provide much relief to investors, as he also said that there is a long way to go before a full recovery.
Yesterday's trading session was mixed and investor sentiment was dominated by news of Brexit negotiations resuming and the prospects of further fiscal stimulus in the U.S.
Investor risk appetite was mixed in the last session of the week. Advanced-economy stocks gained but EM equities nudged down, while the USD weakened and commodity prices declined.
New lockdowns in Europe shook investor sentiment yesterday. Volatility jumped to levels not seen since early June and stock markets tumbled across the world (the main U.S. and European indices dropped by close to 4%). Euro area core sovereign yields declined while peripheral spreads rose, and the EUR weakened below $1.18.
In the last session of the week, investors traded cautiously amid growing COVID-19 cases and better-than-expected Q3 GDP releases in the euro area (euro area aggregate +12.7 vs Consensus +9.6; Spain +16.7 vs Consensus +13.5%).
Stock markets soared across the world on Monday as Pfizer and BioNTech announced a breakthrough in their development of a Covid-19 vaccine.